| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |